Last reviewed · How we verify
Epilepsy having focal-onset seizures
Approved treatments
- Xcopri · SK Life Science, Inc.
- Xcopri · Sk Life
Xcopri works by enhancing the activity of a neurotransmitter called GABA, which helps calm down abnormal electrical activity in the brain.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Epilepsy having focal-onset seizures patent landscape — cliff calendar, originator estates, attackable patents
- Epilepsy having focal-onset seizures treatment landscape brief
- Epilepsy having focal-onset seizures treatment updates RSS
Frequently asked questions about Epilepsy having focal-onset seizures
What drugs treat Epilepsy having focal-onset seizures?
Tracked treatments include Xcopri.
What is the treatment for Epilepsy having focal-onset seizures?
Standard treatment for Epilepsy having focal-onset seizures includes Xcopri. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Epilepsy having focal-onset seizures patent cliff · Epilepsy having focal-onset seizures CI report
- Treatment: Xcopri · SK Life Science, Inc.
- Treatment: Xcopri · Sk Life
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing